Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 sept. 2024 10h20 HE | Source: Spherix Global Insights

The Highly Anticipated FDA Approvals of Galderma’s Nemolizumab and Eli Lilly’s Lebrikizumab are Expected to Shift Dermatologists’ Perceptions of the Atopic Dermatitis Market

EXTON, PA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Since its 2017 debut as the first advanced systemic treatment for atopic dermatitis (AD), Sanofi/Regeneron’s Dupixent has dominated the US market....
21 août 2023 08h00 HE | Source: Timber Pharmaceuticals

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to Close...
06 mars 2017 10h46 HE | Source: Klox Technologies, Inc.

Klox Technologies and LEO Pharma set up company for BioPhotonic in dermatology

LAVAL, Quebec and BALLERUP, Denmark, March 06, 2017 (GLOBE NEWSWIRE) -- Klox Technologies Inc. (‘Klox’) and LEO Pharma A/S (‘LEO Pharma’) to establish a jointly owned company to further develop and...